Documente Academic
Documente Profesional
Documente Cultură
Distribution accounts for almost 35 percent of the retail cost of a drug. Yet, it hasn't witnessed much
change unlike manufacturing and R&D in the past decade. The reasons are regulatory impediments
(for instance, the sluggish implementation of VAT), and highly fragmented nature of the distribution
network. But now, the distribution network is on the brink of a makeover. With the introduction of
VAT in most states, the squeeze on domestic margins and increasing government pressure to contain
retail drug prices, the reform in the distribution of Indian pharma is imminent, says a report by E&Y
on Indian pharma distribution. The report, 'Reforms in distribution (Health Quotient)' has
prophesised that the next wave of reform in the Indian pharma sector would be in the distribution
network.
Drug distribution in India is layered and regulated. Unlike in the West, where a manufacturer can
directly supply goods at the retail level, products in India move through a chain of intermediaries.